Avivagen Stock Buy Hold or Sell Recommendation
VIV Stock | CAD 0.01 0.00 0.00% |
Assuming the 90 days horizon and your above-average risk tolerance, our recommendation regarding Avivagen is 'Strong Sell'. Macroaxis provides Avivagen buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding Avivagen positions. The advice algorithm takes into account all of Avivagen's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Avivagen's buy or sell advice are summarized below:
Real Value 0.0084 | Hype Value 0.01 | Market Value 0.01 | Naive Value 0.01 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Avivagen given historical horizon and risk tolerance towards Avivagen. When Macroaxis issues a 'buy' or 'sell' recommendation for Avivagen, the advice is generated through an automated system that utilizes algorithms and statistical models.
Avivagen |
Execute Avivagen Buy or Sell Advice
The Avivagen recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Avivagen. Macroaxis does not own or have any residual interests in Avivagen or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Avivagen's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
Not Rated
Avivagen Trading Alerts and Improvement Suggestions
Avivagen generated a negative expected return over the last 90 days | |
Avivagen has some characteristics of a very speculative penny stock | |
Avivagen has a very high chance of going through financial distress in the upcoming years | |
The company reported the revenue of 939.17 K. Net Loss for the year was (6.07 M) with profit before overhead, payroll, taxes, and interest of 400.3 K. | |
Avivagen has accumulated about 3.23 M in cash with (3.12 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.09, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
Latest headline from news.google.com: Closing Bell Avivagen Inc flat on Tuesday - The Globe and Mail |
Avivagen Cash Flow Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Change In Cash | (1.1M) | (421.8K) | 744.1K | (1.1M) | (1.0M) | (955.7K) | |
Free Cash Flow | (3.6M) | (3.4M) | (4.6M) | (3.1M) | (2.8M) | (2.9M) | |
Depreciation | 4.6K | 127.5K | 124.8K | 87.5K | 100.6K | 67.1K | |
Net Income | (4.8M) | (4.8M) | (6.4M) | (6.1M) | (5.5M) | (5.2M) | |
End Period Cash Flow | 1.1M | 664.2K | 1.4M | 290.5K | 334.0K | 317.3K | |
Other Non Cash Items | 993.5K | 1.1M | 2.1M | 1.1M | 1.2M | 1.3M | |
Change To Inventory | 127.5K | 45.8K | (826.0K) | 219.5K | 197.6K | 207.5K | |
Net Borrowings | 2.2M | 685.8K | (859.0K) | (1.1M) | (1.0M) | (959.8K) | |
Change To Netincome | 1.3M | 1.5M | 2.6M | 2.1M | 2.4M | 1.2M |
Avivagen Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Avivagen or Pharmaceuticals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Avivagen's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Avivagen stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | 0.00 | |
β | Beta against NYSE Composite | 0.00 | |
σ | Overall volatility | 0.00 | |
Ir | Information ratio | 0.00 |
Avivagen Volatility Alert
At this time Avivagen exhibits very low volatility. Avivagen is a penny stock. Although Avivagen may be in fact a good investment, many penny stocks are subject to artificial price hype. Make sure you completely understand the upside potential and downside risk of investing in Avivagen. We encourage investors to look for signals such as message board hypes, claims of breakthroughs, email spams, sudden volume upswings, and other similar hype indicators. We also encourage traders to check biographies and work history of company officers before investing in instruments with high volatility. You can indeed make money on Avivagen instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Avivagen Fundamentals Vs Peers
Comparing Avivagen's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Avivagen's direct or indirect competition across all of the common fundamentals between Avivagen and the related equities. This way, we can detect undervalued stocks with similar characteristics as Avivagen or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Avivagen's fundamental indicators could also be used in its relative valuation, which is a method of valuing Avivagen by comparing valuation metrics with those of similar companies.
Better Than Average | Worse Than Average | Compare Avivagen to competition |
Fundamentals | Avivagen | Peer Average |
Return On Asset | -1.93 | -0.14 |
Operating Margin | (10.47) % | (5.51) % |
Current Valuation | 7.61 M | 16.62 B |
Shares Outstanding | 77.69 M | 571.82 M |
Shares Owned By Insiders | 1.11 % | 10.09 % |
Number Of Shares Shorted | 6.25 K | 4.71 M |
Price To Earning | (7.32) X | 28.72 X |
Price To Sales | 0.54 X | 11.42 X |
Revenue | 939.17 K | 9.43 B |
Gross Profit | 400.3 K | 27.38 B |
EBITDA | (846.03 K) | 3.9 B |
Net Income | (6.07 M) | 570.98 M |
Cash And Equivalents | 3.23 M | 2.7 B |
Cash Per Share | 0.09 X | 5.01 X |
Total Debt | 6.09 M | 5.32 B |
Current Ratio | 2.93 X | 2.16 X |
Book Value Per Share | (0.12) X | 1.93 K |
Cash Flow From Operations | (3.12 M) | 971.22 M |
Short Ratio | 7.08 X | 4.00 X |
Earnings Per Share | (0.06) X | 3.12 X |
Target Price | 1.38 | |
Beta | 1.08 | -0.15 |
Market Capitalization | 388.47 K | 19.03 B |
Total Asset | 1.37 M | 29.47 B |
Retained Earnings | (45.19 M) | 9.33 B |
Working Capital | (827.11 K) | 1.48 B |
Net Asset | 1.37 M |
Avivagen Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Avivagen . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Avivagen Buy or Sell Advice
When is the right time to buy or sell Avivagen? Buying financial instruments such as Avivagen Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.2020 | 2021 | 2023 | 2024 (projected) | Other Current Liabilities | 63.8K | 63.8K | 57.4K | 54.5K | Total Assets | 3.5M | 1.4M | 1.6M | 1.8M |
Use Investing Ideas to Build Portfolios
In addition to having Avivagen in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Military Industrial Thematic Idea Now
Military Industrial
A collection of large United States defense contractors including companies involved in production or distribution of aircraft, ships, vehicles, weaponry, and electronic systems in cooperation with the government. The Military Industrial theme has 46 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Military Industrial Theme or any other thematic opportunities.
View All Next | Launch |
Check out Avivagen Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Complementary Tools for Avivagen Stock analysis
When running Avivagen's price analysis, check to measure Avivagen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avivagen is operating at the current time. Most of Avivagen's value examination focuses on studying past and present price action to predict the probability of Avivagen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avivagen's price. Additionally, you may evaluate how the addition of Avivagen to your portfolios can decrease your overall portfolio volatility.
CEOs Directory Screen CEOs from public companies around the world | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation |